home / stock / otic / otic news

OTIC News and Press, Otonomy Inc. From 02/27/20

Stock Information
Company Name: Otonomy Inc.
Stock Symbol: OTIC
Market: OTC
Website: otonomy.com
Menu
OTIC OTIC Quote OTIC Short OTIC News OTIC Articles OTIC Message Board
Get OTIC Alerts

News, Short Squeeze, Breakout and More Instantly...
OTIC - Otonomy Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Results from three clinical trials expected in 2020 including the Phase 3 trial of OTIVIDEX™  in Ménière’s disease Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. ET SAN DIEGO, Feb. 27, 2020 (GLOBE ...
OTIC - Otonomy to Present at Two Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D., president and chief executive officer, is scheduled to present at ...

OTIC - Otonomy to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the fourth quarter and full year 2019 as well as provide ...

OTIC - Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program

SAN DIEGO, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced preclinical results from the company’s gene therapy collaboration with Applied Genetic ...
OTIC - Otonomy updates on product pipeline

Otonomy ( OTIC +1% ) provides an update on its product pipeline. More news on: Otonomy, Inc., Healthcare stocks news, Read more ...

OTIC - Otonomy Provides Corporate and Product Pipeline Update

Three programs with clinical trial results in 2020 including OTIVIDEX™  Phase 3 trial in Ménière’s disease Current capital funds operations into 2021 SAN DIEGO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceuti...

OTIC - NIO, SDRL, CTIC and AGRX among midday movers

Gainers:  CLPS (NASDAQ: CLPS )  +68% . More news on: CLPS Incorporation, Microbot Medical Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...

OTIC - MBOT, NLNK among premarket gainers

Soleno Therapeutics (NASDAQ: SLNO ) +15% . More news on: Soleno Therapeutics, Inc., Proteostasis Therapeutics, Inc., Microbot Medical Inc., Stocks on the move, Read more ...

OTIC - CVM, NLNK, PD and CLSD among after hours movers

Gainers: NLNK   +14.3% . OTIC   +5.2% . PD   +4.1% . KNSL   +3.0% . CLSD   +2.9% . More news on: NewLink Genetics Corporation, Otonomy, Inc., PagerDuty, Inc., Stocks on the move, , News on ETFs Read more ...

OTIC - Otonomy +5% on new bullish start

Oppenheimer starts Otonomy (NASDAQ: OTIC ) with an Outperform rating and $8 price target, a 217% upside. The company has a Very Bullish average Sell Side rating . More news on: Otonomy, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Previous 10 Next 10